Member Info for NoMark

Ok mate. £2.7 mil cash balance plus £10 mil raised minus expenses. Hopefully there is still plenty left.

Ok thanks old boy

Cheers mate

Which RNS Begger?

Needs to get its interims out of the way and show what cash position it’s in.

Just heard that on Radio 6 news Watchman. Good news.

Buy on NEX 13.3885

Positives definately overtaking the negatives now. Should see a decent rise

Minimum Interims by end of Sept but sounds like there will be much more.

Nothing much on offer?

Hearing the RDR

To buy

Makes sense Strongman

The 353k is down as a sell on here. There is some tinkering going on

Probably not a good idea to try and short it again with news/media on the horizon

Look like they are drying up.

Broken

Tue 06:51 Price: 14.40 a-2-b 1,174 posts RE: IMM Can't remember which one it was: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763516/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116859/ http://www.pmlive.com/pharma_thought_leadership/managed_access_programmes_a_powerful_source_of_real-world_insight_1184311?SQ_DESIGN_NAME=2& No Opinion Reply to postReport post Tue 06:36 Price: 14.40 StockTracker 18 posts RE: IMM Link please sounds interesting Strong Buy Reply to postReport post Tue 06:27 Price: 14.40 a-2-b 1,174 posts IMM Just read a paper on MAP was fairly interesting apparently its a good route to market and data obtained it quite valuable in many different aspects plus advertising before the release of a drug to garuntee a large uptake in the initial year. With the open label they're definitely going overkill on the data to help with approval. Good results adhering to findings and showing enhanced safety profile will definitely get this to market.

Bloody hope so

Wiped by the looks